Literature DB >> 22866160

DRO1 sensitizes colorectal cancer cells to receptor-mediated apoptosis.

Andreas Herbst1, Constanze Bayer, Claudia Wypior, Frank T Kolligs.   

Abstract

The molecule DRO1 (down‑regulated by oncogenes 1) is a potential tumor suppressor protein that is frequently down‑regulated in primary colorectal cancers and colorectal cancer cell lines. Although the mechanism of DRO1 action has yet to be elucidated, previous data have suggested that DRO1 interferes with tumor growth by sensitizing cells to apoptosis. The effect of DRO1 expression on receptor-, mitochondrial- and endoplasmic reticulum‑mediated apoptosis in colorectal cancer cell lines was analyzed in this study, following the generation of DLD1/DRO1 and HCT116/DRO1 cell lines. Cells were cultured, and then analyzed using flow cytometry. DRO1 was found to sensitize cells to receptor-mediated apoptosis by promoting the activation of components of the death-inducing signaling complex (DISC).

Entities:  

Year:  2011        PMID: 22866160      PMCID: PMC3408059          DOI: 10.3892/ol.2011.356

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  10 in total

1.  The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development.

Authors:  I Bergqvist; M Eriksson; J Saarikettu; B Eriksson; B Corneliussen; T Grundström; D Holmberg
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

Review 2.  How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  Trends Cell Biol       Date:  2008-03-07       Impact factor: 20.808

Review 3.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

4.  DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.

Authors:  Guido T Bommer; Claudia Jäger; Eva-Maria Dürr; Sebastian Baehs; Sören T Eichhorst; Thomas Brabletz; Gang Hu; Thomas Fröhlich; Georg Arnold; Dagmar C Kress; Burkhard Göke; Eric R Fearon; Frank T Kolligs
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

Review 5.  Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.

Authors:  Bodvaël Pennarun; Annemieke Meijer; Elisabeth G E de Vries; Jan H Kleibeuker; Frank Kruyt; Steven de Jong
Journal:  Biochim Biophys Acta       Date:  2009-12-02

Review 6.  Bcl-2 family on guard at the ER.

Authors:  Eva Szegezdi; David C Macdonald; Tríona Ní Chonghaile; Sanjeev Gupta; Afshin Samali
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-11       Impact factor: 4.249

Review 7.  Biochemical analysis of the native TRAIL death-inducing signaling complex.

Authors:  Henning Walczak; Tobias L Haas
Journal:  Methods Mol Biol       Date:  2008

8.  Changes in FADD levels, distribution, and phosphorylation in TNFalpha-induced apoptosis in hepatocytes is caspase-3, caspase-8 and BID dependent.

Authors:  Xiaoying Zhang; Raghuveer Vallabhaneni; Patricia A Loughran; Richard Shapiro; Xiao-Min Yin; Youzhong Yuan; Timothy R Billiar
Journal:  Apoptosis       Date:  2008-08       Impact factor: 4.677

9.  A novel apoptotic pathway induced by the drs tumor suppressor gene.

Authors:  Yukihiro Tambe; Takahiro Isono; Seiki Haraguchi; Atsuko Yoshioka-Yamashita; Masuo Yutsudo; Hirokazu Inoue
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

10.  Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.

Authors:  Georg W Bornkamm; Christian Berens; Conny Kuklik-Roos; Jean-Marie Bechet; Gerhard Laux; Jürgen Bachl; Martin Korndoerfer; Martin Schlee; Michael Hölzel; Anastassia Malamoussi; Rob D Chapman; Falk Nimmerjahn; Josef Mautner; Wolfgang Hillen; Hermann Bujard; Jean Feuillard
Journal:  Nucleic Acids Res       Date:  2005-09-07       Impact factor: 16.971

  10 in total
  4 in total

1.  The function of FAK/CCDC80/E-cadherin pathway in the regulation of B16F10 cell migration.

Authors:  Guoshun Pei; Yan Lan; Weijie Lu; Lina Ji; Zi-Chun Hua
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

2.  Cell type-dependent function of LATS1/2 in cancer cell growth.

Authors:  Wei-Wei Pan; Toshiro Moroishi; Ja Hyun Koo; Kun-Liang Guan
Journal:  Oncogene       Date:  2018-12-10       Impact factor: 9.867

3.  Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.

Authors:  Eunji Hong; Sujin Park; Akira Ooshima; Chang Pyo Hong; Jinah Park; Jin Sun Heo; Siyoung Lee; Haein An; Jin Muk Kang; Seok Hee Park; Joon Oh Park; Seong-Jin Kim
Journal:  Sci Rep       Date:  2020-02-19       Impact factor: 4.379

4.  Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis.

Authors:  Jessica I Christian; Agnieszka Pastula; Andreas Herbst; Jens Neumann; Maximilian K Marschall; Andrea Ofner; Heike Zierahn; Marlon R Schneider; Eckhard Wolf; Michael Quante; Frank T Kolligs
Journal:  Oncotarget       Date:  2022-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.